Fortrea Holdings Inc. Common Stock
FTREStock
$17.92+279.45%52W
Market Cap$1.69B
P/E—
Div yield—
Beta2.04
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-7.06%
Price vs S&P 500 (4W)11.48%
VGM Score54.49
Market Capitalization$1.69B
Earnings Surprise History
Q1 260.16est. 0.05
Analyst Recommendations
Mar 2026
Apr 2026
May 2026
Jun 2026
3.71
3.76
3.76
3.76
Industry Peers — Health Services(29)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
FTREFortrea Holdings Inc. Common Stock | B | F | A | $17.92 |
| NTRANatera, Inc. Common Stock | F | A | B | $269.83 |
| DGXQuest Diagnostics Inc. | C | D | C | $209.41 |
| LHLabcorp Holdings Inc. | C | D | C | $281.94 |
| GHGuardant Health, Inc. Common Stock | F | A | A | $155.00 |
| EXASExact Sciences Corp | F | B | B | $0.00 |
| BLLNBillionToOne, Inc. Class A Common Stock | F | F | B | $128.18 |
| RDNTRadNet, Inc. Common Stock | D | C | C | $62.99 |
| CAICaris Life Sciences, Inc. Common Stock | F | A | D | $16.48 |
| VCYTVeracyte, Inc. | D | A | A | $59.22 |
| CELCCelcuity Inc. Common Stock | — | — | B | $88.29 |
About
Fortrea is a global contract research organization providing comprehensive clinical trial management, pharmacology, and patient access solutions for biopharma, medical device, and diagnostic companies. The company offers flexible engagement models ranging from functional services to full-service trial management. Spun off from Labcorp in 2023, Fortrea operates as an independent public company with approximately 19,000 employees across 90 countries.